This document discusses early cancer detection technologies and methods. It begins with a debate on the pros and cons of early detection screening, then discusses the history of cervical cancer screening and its success. It also covers the high costs of cancer care. The bulk of the document focuses on liquid biopsy technologies for detecting cancer DNA in blood and their potential for early detection and monitoring. Specific technologies like Grail and Cologuard stool DNA testing are discussed. Challenges to adoption like guidelines, costs, regulation and education are also covered.